DBV Technologies S.A. (DBVT) vs Prime Medicine (PRME)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
DBV Technologies S.A. (DBVT) has outperformed Prime Medicine (PRME) over the past year, losing 31.4% versus a loss of 33.6%. Prime Medicine is the larger company by market cap ($707.4 million vs $614.0 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | DBVT | PRME |
|---|---|---|
| Share price | $9.77 | $3.90 |
| Market cap | $614.03M | $707.37M |
| 1-day change | -2.10% | +11.43% |
| YTD return | -49.03% | +12.39% |
| 1-year return | -31.39% | -33.56% |
| EPS (TTM) | $-3.50 | $-1.07 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $26.19 | $6.85 |
| 52-week low | $9.64 | $2.67 |
| Distance from 52-week high | -62.69% | -43.07% |
| Average volume | 325.32K | 3.32M |
| Shares outstanding | 62.85M | 181.38M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
DBVT vs PRME FAQ
Which is bigger, DBV Technologies S.A. or Prime Medicine?
Prime Medicine (PRME) is larger, with a market capitalization of $707.37M compared with $614.03M for DBV Technologies S.A. (DBVT).
Which stock has performed better over the past year, DBVT or PRME?
DBVT returned -31.39% over the past 12 months, compared with -33.56% for PRME (price return, excluding dividends). Past performance does not predict future results.
Are DBV Technologies S.A. and Prime Medicine in the same industry?
Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.